Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma

NCT00849251 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped One of the study drugs is not available.

Conditions

Refractory Multiple Myeloma
Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

DRUG: cyclophosphamide
DRUG: pegylated liposomal doxorubicin hydrochloride
DRUG: bortezomib
DRUG: dexamethasone

Sponsor

University of Washington

Collaborators

[object Object]